Based on the important role of PD1/PD-L1 signaling in autoimmunity, this pathway has become a new therapeutic target for ameliorating autoimmune diseases by increasing the expression of PD-L1 or triggering PD1. The gene discussed is CD274; the disease is autoimmune disease.